Blackrock’s Sending THIS Crypto Higher on Purpose

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

Kristin Peck Biography and Net Worth

CEO of Zoetis

Prior to becoming CEO, Ms. Peck was executive vice president and group president, U.S. Operations, Business Development and Strategy at Zoetis. Ms. Peck helped usher Zoetis through its Initial Public Offering in 2013 and has been a driving force of change in many roles at the company including Global Manufacturing and Supply, Global Poultry, Global Diagnostics, Corporate Development, and New Product Marketing and Global Market Research.

Before joining Zoetis, Ms. Peck served as executive vice president, Worldwide Business Development and Innovation at Pfizer Inc. and as a member of Pfizer's Executive Leadership Team. In this role, she was responsible for the evaluation of strategic alternatives for Pfizer's Animal Health and Nutrition businesses – paving the way for a public animal health company and attractive investment opportunity.

Prior to joining Pfizer, Ms. Peck held roles at The Boston Consulting Group (BCG) as well as in private equity and real estate finance at The Prudential Realty Group, The O'Connor Group and J.P. Morgan.

Ms. Peck is on the Board of BlackRock, the world’s largest asset management firm. She is also a member of the Business Roundtable and a Board member of Catalyst, a global non-profit that helps companies around the world accelerate women into leadership. In addition, she serves on the Advisory Board for the Deming Center for Quality, Productivity and Competitiveness at Columbia Business School. Named a Fortune 2020 Businessperson of the Year, Ms. Peck has been recognized for her leadership and Zoetis' strong performance, including its resilience during the COVID-19 pandemic.

Ms. Peck holds a bachelor's degree from Georgetown University and an MBA from Columbia Business School.

What is Kristin C. Peck's net worth?: The estimated net worth of Kristin C. Peck is at least $9.99 million as of November 21st, 2023. Ms. Peck owns 56,843 shares of Zoetis stock worth more than $9,985,610 as of November 21st. This net worth approximation does not reflect any other assets that Ms. Peck may own. Additionally, Ms. Peck receives an annual salary of $3,540,000.00 as CEO at Zoetis. Learn More about Kristin C. Peck's net worth.
How old is Kristin C. Peck?: Ms. Peck is currently 53 years old. There are 7 older executives and no younger executives at Zoetis. Learn More on Kristin C. Peck's age.
What is Kristin C. Peck's salary?: As the CEO of Zoetis Inc., Ms. Peck earns $3,540,000.00 per year. Learn More on Kristin C. Peck's salary.
How do I contact Kristin C. Peck?: The corporate mailing address for Ms. Peck and other Zoetis executives is 10 Sylvan Way, Parsippany NJ, 07054. Zoetis can also be reached via phone at (973) 822-7000 and via email at [email protected]. Learn More on Kristin C. Peck's contact information.
Has Kristin C. Peck been buying or selling shares of Zoetis?: Kristin C. Peck has not been actively trading shares of Zoetis during the past quarter. Most recently, Kristin C. Peck sold 13,000 shares of the business's stock in a transaction on Tuesday, November 21st. The shares were sold at an average price of $176.84, for a transaction totalling $2,298,920.00. Following the completion of the sale, the chief executive officer now directly owns 56,843 shares of the company's stock, valued at $10,052,116.12. Learn More on Kristin C. Peck's trading history.
Who are Zoetis' active insiders?: Zoetis' insider roster includes Juan Alaix (Director), Heidi Chen (EVP), Glenn David (EVP), Andrew Fenton (EVP), Wetteny Joseph (Exec. VP & CFO ), Robert Kelly (EVP), Catherine Knupp (EVP), Roxanne Lagano (EVP), Clinton Lewis, Jr. (EVP), Gregory Norden (Director), Kristin Peck (CEO), Robert Polzer (EVP), Willie Reed (Director), Linda Rhodes (Director), Robert Scully (Director), and Roman Trawicki (EVP). Learn More on Zoetis' active insiders.
Are insiders buying or selling shares of Zoetis?: In the last twelve months, insiders at the sold shares 6 times. They sold a total of 18,632 shares worth more than $3,346,903.01. The most recent insider tranaction occured on April, 18th when EVP Roxanne Lagano sold 923 shares worth more than $139,529.91. Insiders at Zoetis own 0.2% of the company. Learn More about insider trades at Zoetis.
Information on this page was last updated on 4/18/2024.

Kristin C. Peck Insider Trading History at Zoetis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/21/2023	Sell	13,000	$176.84	$2,298,920.00	56,843
8/22/2023	Sell	13,000	$179.97	$2,339,610.00	56,843
7/21/2022	Sell	9,689	$180.00	$1,744,020.00	39,743
7/7/2022	Sell	311	$180.00	$55,980.00	39,743
2/25/2022	Sell	10,000	$192.29	$1,922,900.00
11/26/2021	Sell	14,500	$223.10	$3,234,950.00
8/25/2021	Sell	14,500	$203.55	$2,951,475.00	43,424
11/25/2020	Sell	10,500	$161.51	$1,695,855.00	38,374
8/25/2020	Sell	10,500	$157.61	$1,654,905.00	42,374
5/26/2020	Sell	10,500	$131.31	$1,378,755.00	43,759
2/25/2020	Sell	11,925	$138.10	$1,646,842.50	51,799
11/12/2019	Sell	11,500	$117.16	$1,347,340.00	44,877
8/12/2019	Sell	11,500	$123.22	$1,417,030.00	48,877
5/13/2019	Sell	11,500	$100.92	$1,160,580.00
2/12/2019	Sell	11,500	$86.79	$998,085.00
11/12/2018	Sell	11,500	$94.78	$1,089,970.00
8/1/2018	Sell	5,000	$86.22	$431,100.00
5/1/2018	Sell	4,877	$83.46	$407,034.42	42,652
11/22/2016	Sell	10,092	$49.55	$500,058.60	22,768

Kristin C. Peck Buying and Selling Activity at Zoetis

Zoetis Company Overview

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Today's Range

Now: $175.67

$173.83

$177.41

50 Day Range

MA: $186.18

$170.37

$196.48

2 Week Range

Now: $175.67

$144.80

$201.92

Volume

2,186,455 shs

Average Volume

2,913,613 shs

Market Capitalization

$79.26 billion

P/E Ratio

33.02

Dividend Yield

0.98%

Beta

0.9

Blackrock’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

Kristin Peck Biography and Net Worth

What is Kristin C. Peck's net worth?

How old is Kristin C. Peck?

What is Kristin C. Peck's salary?

How do I contact Kristin C. Peck?

Has Kristin C. Peck been buying or selling shares of Zoetis?

Who are Zoetis' active insiders?

Are insiders buying or selling shares of Zoetis?